TLS Advisors LLC - Q3 2023 holdings

$24.7 Thousand is the total value of TLS Advisors LLC's 15 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 33.3% .

 Value Shares↓ Weighting
RRC SellRANGE RESOURCES CORP$1,553
-10.0%
47,923
-18.5%
6.28%
-15.1%
XENE SellXENON PHARMACEUTICALS INC$1,126
-13.4%
32,956
-2.4%
4.56%
-18.3%
GTEC ExitGREENLAND TECHNOLOGIES HOLDI$0-12,054
-100.0%
-0.08%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
EQT CORPORATION4Q3 202326.4%
OVID THERAPEUTICS INC4Q3 202320.5%
META PLATFORMS INC CLASS A COMMON STOCK COMMON STOCK4Q3 202313.0%
XOMA CORP COM4Q3 202313.1%
OMNIAB INC REG SHS COM4Q3 20236.9%
XENON PHARMACEUTICALS INC SHS4Q3 20236.6%
RANGE RESOURCES CORP4Q3 20238.1%
HOVNANIAN ENTERPRISES INC COM4Q3 20231.6%
ISHARES MSCI SINGAPORE ETF4Q3 20231.4%
YANDEX NV-A4Q3 20231.7%

View TLS Advisors LLC's complete holdings history.

Latest significant ownerships (13-D/G)
TLS Advisors LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Ovid Therapeutics Inc.May 27, 20202,489,4154.6%

View TLS Advisors LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-07
13F-HR2024-02-14
13F-HR2023-11-16
13F-HR2023-11-16
13F-HR2023-11-16
13F-HR2023-02-14
SC 13D/A2020-05-27
SC 13D/A2019-11-27
SC 13D/A2019-10-07
SC 13D2019-03-01

View TLS Advisors LLC's complete filings history.

Compare quarters

Export TLS Advisors LLC's holdings